Efficacy and Safety of Once-Weekly Efpeglenatide Monotherapy Versus Placebo in Type 2 Diabetes: The AMPLITUDE-M Randomized Controlled Trial

por Frias, Juan Pablo, Choi, JaeDuk, Rosenstock, Julio, Popescu, Luiza, Niemoeller, Elisabeth, Muehlen-Bartmer, Isabel, Baek, Seungjae
Publicado 2022

Efficacy and Safety of Flexible Versus Fixed Dosing Intervals of Insulin Glargine 300 U/mL in People with Type 2 Diabetes

por Riddle, Matthew C., Bolli, Geremia B., Home, Philip D., Bergenstal, Richard M., Ziemen, Monika, Muehlen-Bartmer, Isabel, Wardecki, Marek, Vinet, Laetitia, Jeandidier, Nathalie, Yki-Järvinen, Hannele
Publicado 2016

Erratum. A Randomized Controlled Trial Comparing Efficacy and Safety of Insulin Glargine 300 Units/mL Versus 100 Units/mL in Older People With Type 2 Diabetes: Results From the SEN...

por Ritzel, Robert, Harris, Stewart B., Baron, Helen, Florez, Hermes, Roussel, Ronan, Espinasse, Melanie, Muehlen-Bartmer, Isabel, Zhang, Nianxian, Bertolini, Monica, Brulle-Wohlhueter, Claire, Munshi, Medha, Bolli, Geremia B.
Publicado 2019